Abstract
We analyzed the histological high-risk factors for recurrence of submucosal invasive carcinomas (pT1) of the colon and rectum after endoscopic therapy, examining pT1 cancers treated primarily by endoscopic resection within a 23-year period. We compared recurrent and nonrecurrent cancers, evaluating the following “highrisk factors” of the primary lesion: massive invasion, a surgical margin <2 mm but negativity for cancer in the cut end, poorly differentiated adenocarcinoma (PD) (G3), undifferentiated carcinoma (G4), and/or positive angiolymphatic invasion. The following histological factors were defined as predictive of a low risk: minimum invasion, a surgical margin >2 mm, well or moderately differentiated adenocarcinoma (G1, G2), and no evidence of angiolymphatic invasion. We analyzed the records of 37 patients with pT1 cancers, including 15 with high-risk factors who underwent subsequent resection. Local recurrence with or without liver metastases developed in 4 of these 15 patients. The histological type was PD in three (75%) of the four recurrent lesions. All four (100%) lesions showed a desmoplastic response (DR). Only 1 (9%) of the 11 patients without recurrence after subsequent surgery had a lesion with a small component of PD, and only three (27%) lesions showed a mild DR. We concluded that endoscopic therapy is inadequate for pT1 cancers with a histological PD component, and/or a DR in the cancer stroma.
Similar content being viewed by others
References
Mainprize KS, McC Mortensen NJ, Warren BF. Early colorectal cancer: recognition, classification and treatment. Br J Surg 1998;85:469–476.
Hackelsberger A, Fruhmorgen P, Weiler H, Heller T, Seeliger H, Junghanns K. Endoscopic polypectomy and management of colorectal adenomas with invasive carcinoma. Endoscopy 1995;27:153–158.
Fruhmorgen P, Rufle W, Kobras S, Seeliger H, Herrmann G. Endoscopic therapy of early colorectal cancer (pT1) — A prospective study. Z Gastroenterol 2003;41:703–710.
Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology 1985;89:328–336.
Nivatvongs S, Rojanasakul A, Reiman HM, Dozois RR, Wolff BG, Pemberton JH, et al. The risk of lymph node metastasis in colorectal polyps with invasive adenocarcinoma. Dis Colon Rectum 1991;34:323–328.
Sugihara K, Muto T, Morioka Y. Management of patients with invasive carcinoma removed by colonoscopic polypectomy. Dis Colon Rectum 1989;32:829–834.
Cranley JP, Petras RE, Carey WD, Paradis K, Sivak MV. When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma? Gastroenterology 1986;91:419–427.
Volk EE, Goldblum JR, Petras RE, Paradis K, Sivak MV. Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology 1995;109:1801–1807.
Williams CB, Saunders BP, Talbot IC. Endoscopic management of polypoid early colon cancer. World J Surg 2000;24:1047–1051.
Seitz U, Bohnacker S, Seewald S, Thonke F, Brand B, Braiutigam T, et al. Is endoscopic polypectomy an adequate therapy for malignant colorectal adenomas? Presentation of 114 patients and review of the literature. Dis Colon Rectum 2004;47:1789–1796.
Morson BC, Whieway JE, Jones EA, Macrae FA, Williams CB. Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut 1984;25:437–444.
Hewitt RE, Powe DG, Carter GI, Turner DR. Desmoplasia and its relevance to colorectal tumor invasion. Int J Cancer 1993;53:62–69.
Nakada I, Tasaki T, Ubukata H, Goto Y, Watanabe Y, Sato S, et al. Desmoplastic response in biopsy specimens of early colorectal carcinoma is predictive of deep submucosal invasion. Dis Colon Rectum 1998;41:896–900.
Caporale A, Cosenza UM, Vestri AR, Costi U, Galati G, Cannaviello C, et al. Has desmoplastic response extent protective action against tumor aggressiveness in gastric carcinoma? J Exp Clin Cancer Res 2001;20:21–24.
Coverlizza S, Risio M, Ferrari A, Fenoglio-Preiser CM, Rossini FP. Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential. Cancer 1989;64:1937–1947.
Risio M, Fiocca R. Malignant adenoma: diagnosis, staging, risk factors, lymph node involvement and problems of sampling. Tech Coloproctol 2004;8Suppl 2:253–256.
Halvorsen TB, Seim E. Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer. J Clin Pathol 1989;42:162–166.
Wernert N, Locherbach C, Wellmann A, Behrens P, Hugel A. Presence of genetic alterations in microdissected stroma of human colon and breast cancers. Anticancer Res 2001;21:2259–2264.
Ishiguro A, Uno Y, Ishiguro Y, Munakata A, Morita T. Correlation of lifting versus non-lifting and microscopic depth of invasion in early colorectal cancer. Gastrointest Endosc 1999;50:329–333.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakada, I., Tabuchi, T., Nakachi, T. et al. Histological factors contributing to a high risk of recurrence of submucosal invasive cancer (pT1) of the colon and rectum after endoscopic therapy. Surg Today 38, 675–678 (2008). https://doi.org/10.1007/s00595-007-3701-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-007-3701-7